Align Technology (ALGN) closed at $166.00 on November 6, 2026, up 4.2% from the previous close, on volume of 1,672,249 shares (30-day average 963,574).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 12, 2026 | Put with Delta Hedge | 20-Nov-26 140 P +40,000 Stock | 1,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Align Technology Recognized in Extel's 2026 All-America Executive Team Rankings
Business Wire (Fri, 6-Nov 12:59 PM ET)
Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
Business Wire (Fri, 6-Nov 9:10 AM ET)
Align Technology Announces $270 Million Share Repurchase Agreement
TipRanks (Fri, 6-Nov 6:56 AM ET)
Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
Business Wire (Mon, 2-Nov 4:00 PM ET)
Align Technology Announces Third Quarter 2026 Financial Results
Business Wire (Wed, 28-Oct 4:05 PM ET)
Align Technology Announces CEO Succession Plan
Business Wire (Wed, 28-Oct 4:05 PM ET)
Business Wire (Mon, 26-Oct 9:00 AM ET)
Business Wire (Fri, 16-Oct 9:11 PM ET)
Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
Business Wire (Thu, 1-Oct 8:30 AM ET)
Business Wire (Tue, 29-Sep 8:06 AM ET)
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling a lion's share of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. Invisalign treats over 2 million cases annually, or roughly 10% of all orthodontic cases and has treated over 20 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Align Technology trades on the NASDAQ stock market under the symbol ALGN.
As of November 6, 2026, ALGN stock price climbed to $166.00 with 1,672,249 million shares trading.
ALGN has a beta of 0.79, meaning it tends to be less sensitive to market movements. ALGN has a correlation of 0.07 to the broad based SPY ETF.
ALGN has a market cap of $11.79 billion. This is considered a Large Cap stock.
Last quarter Align Technology reported $1 billion in Revenue and $2.80 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.13.
In the last 3 years, ALGN traded as high as $335.40 and as low as $122.00.
The top ETF exchange traded funds that ALGN belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.
ALGN has outperformed the market in the last year with a price return of +24.1% while the SPY ETF gained +10.8%. ALGN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -1.8% and +7.4%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
ALGN support price is $155.57 and resistance is $163.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALGN shares will trade within this expected range on the day.
